title: Interventional and synthetic therapy of advanced hepatocellular carcinoma.
abstract: OBJECTIVE
  To evaluate the clinical efficacy of interventional therapy in the treatment of hepatocellular carcinoma (HCC).
  
  
  METHODS
  Thirty-three patients with HCC were synthetically treated by systematic measures. Among them, percutaneous port-catheter system (PCS) implantation via the femoral artery was performed in 21 cases. Patients with haemorrhage were treated with prothrombin complex concentrate and fibroraas, and patients with hepatic encephalopathy by branched-chain amino acids and arginine.
  
  
  RESULTS
  All indwelling catheters of PCS were patent and no catheter tip dislocations were observed. Of 33 patients with advanced HCC, the mean survival rate was 20.1 months and 12 (36%) patients survived more than 2 years.
  
  
  CONCLUSIONS
  Patients with advanced HCC were treated by synthetic measures. Survival was prolonged, quality of life was improved significantly, and the effectiveness of interventional therapy was further improved.
authors.affiliation: Department of Radiology, General Hospital, Tianjin Medical University, Tianjin 300052, China.
authors.forename: Xicai
authors.initials: X
authors.lastname: Cao
authors.forename: Nengshu
authors.initials: N
authors.lastname: He
authors.forename: Jianzhong
authors.initials: J
authors.lastname: Sun
authors.forename: Song
authors.initials: S
authors.lastname: Wang
authors.forename: Xunming
authors.initials: X
authors.lastname: Ji
authors.forename: Hailun
authors.initials: H
authors.lastname: Fan
authors.forename: Jinsheng
authors.initials: J
authors.lastname: Wang
authors.forename: Changlin
authors.initials: C
authors.lastname: Zhang
authors.forename: Jianguo
authors.initials: J
authors.lastname: Yang
authors.forename: Tiwen
authors.initials: T
authors.lastname: Lu
authors.forename: Jianhua
authors.initials: J
authors.lastname: Li
authors.forename: Guoxin
authors.initials: G
authors.lastname: Zhang
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000628:therapy*; D002408:Catheters, Indwelling; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate